clinicaltrials.gov

RSS kanal za ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days

Q: Koji je URL RSS kanala za ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days?

Adresa RSS kanala je https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=Rozanolixizumab+%28UCB7665%29&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000. Zalijepite je u bilo koji RSS čitač ili kliknite Prati odmah da biste ga čitali u aplikaciji Feeder.

Q: Radi li RSS kanal za ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days?

Da. Feeder ga je provjerio prije oko 1 sat, a RSS kanal odgovorio je normalno.

Q: Kako pratiti ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days u aplikaciji Feeder?

Kliknite Prati odmah i registrirajte se ako još nemate račun. Feederov besplatni plan obuhvaća do 200 izvora na webu, iPhoneu i Androidu. Kreditna kartica nije potrebna.

Primaj najnovije objave od ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days odmah čim se pojave.

Prati odmah < 10 pratitelja

O ovom RSS kanalu

Lists interventional clinical trials for rozanolixizumab (UCB7665) across various phases and conditions, updated within the last 14 days.

Status: Radi Provjereno prije oko 1 sat, svakih oko 2 sata
Objave: Otprilike jednom tjedno Posljednja objava prije 4 dana
Jezik: English
Pratitelji: < 10
Web-stranica: clinicaltrials.gov
URL RSS sažetka: https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=Rozanolixizumab+%28UCB7665%29&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000

Provjerite ovaj kanal u RSS validatoru

Pronađite RSS kanal drugog web-mjesta

Najnovije objave

Čitajte ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days tamo gdje inače čitate

Pratite u aplikaciji Feeder Čitajte ga uz sve ostalo što pratite, na webu, iPhoneu i Androidu. E-mail bilteni Pretvorite čitanje u bilten bez napuštanja Feeder. RSS na Telegram Vaši RSS izvori, isporučeni na Telegram. Nahranite svoj AI Povežite Claude, ChatGPT i Cursor sa svojim feedovima putem MCP-a AI sažeci Saznajte bit, uz izvore za provjeru. Pretvaranje teksta u govor Pretvorite svoj popis za čitanje u podcast.

Pitanja

Koji je URL RSS kanala za ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days?

Adresa RSS kanala je https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=Rozanolixizumab+%28UCB7665%29&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000. Zalijepite je u bilo koji RSS čitač ili kliknite Prati odmah da biste ga čitali u aplikaciji Feeder.

Koliko često ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days objavljuje?

ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days objavljuje otprilike jednom tjedno. Posljednja objava bila je prije 4 dana.

Radi li RSS kanal za ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days?

Da. Feeder ga je provjerio prije oko 1 sat, a RSS kanal odgovorio je normalno.

Kako pratiti ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days u aplikaciji Feeder?

Kliknite Prati odmah i registrirajte se ako još nemate račun. Feederov besplatni plan obuhvaća do 200 izvora na webu, iPhoneu i Androidu. Kreditna kartica nije potrebna.

Pratite ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days u Feederu

Feederov besplatni plan obuhvaća do 200 izvora na webu, iPhoneu i Androidu. Kreditna kartica nije potrebna.

Registriraj se besplatno

Ili se prijavite